HIV/AIDS Therapy
Invirase receives FDA marketing approval
Published in Medical Letter on the CDC and FDA, January 23rd, 2005
The new 500 mg formulation will significantly reduce Invirase's pill count by more than half, from five to two pills twice a day. With less tablets per day, Invirase now becomes an excellent choice for HIV-patients who require treatment with an HIV-protease inhibitor.
"With the new Invirase 500 mg tablet now available, pill burden is considerably reduced and we anticipate that this improved convenience together with boosted Invirase's record of convincing data will result in an expansion of its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bacteriology
Bacteria identified in juice using FT-near infrared spectroscopy - Diagnostics
Diagnosis of meningococcal disease with immunohistochemistry and PCR outlined - Environmental Health
Communication of information from toxic agents registry to public outlined - Food Safety
Vibrio parahaemolyticus quantified in oysters using PCR - Radiation Therapy
Radiation doses in pediatric radiology discussed - Adverse Drug Events
Expert calls for less direct-to-consumer advertising - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
